In fact, the size of putative transporters might be large enough to carry not a single, but numerous viral particles
GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers
The data is earlier-stage and most of the human work comes from outside the U.S
For a deeper look at that mechanism, see how GLP-1 actually works for weight loss
If youre about to start semaglutide for weight management, you might wonder what the first few doses will feel like and what changes to expect
A study of the efficacy and safety of dulaglutide (LY2189265) in participants with type 2 diabetes - Full Text View - ClinicalTrials.gov